Nelvik Pharma Inc. is seeking a senior regulatory advisor for a focused biologics/vaccine pathway assessment. Note: this is a short-term advisory mandate to support internal investment decision‑making. The mandate relates to a contemplated vaccine platform intended to support export, access, and potential technology‑transfer initiatives. We are looking to speak with advisors who have direct experience with one or more of the following: Health Canada biologics/vaccine pathways BRDD engagement Experience with LATAM regulatory authorities NDS / CTA pathway strategy CMC strategy for biologics or vaccines GMP, lot release, stability, analytical validation, and batch-consistency expectations clinical immunogenicity and safety bridging considerations export-related regulatory questions, including DEL/GMP, CPP, or Section 37 considerations right-of-reference and technology-transfer diligence Relevant backgrounds may include Health Canada, vaccine manufacturers, biologics-focused regulatory consulting, CDMOs, CROs, or senior CMC/regulatory strategy roles. #J-18808-Ljbffr

📌 Payments Regulatory Advisor - Capital One Canada (Toronto)
🏢 Capital One - Canada
📍 Toronto